1 Yi, Z., Fu, Y., Zhao, S., Zhang, X. & Ma, C. Differential expression of miRNA patterns in renal cell carcinoma and nontumorous tissues. J Cancer Res Clin Oncol 136, 855-862, doi:10.1007/s00432-009-0726-x (2010).
2 Cohen, H. T. & McGovern, F. J. Renal-cell carcinoma. N Engl J Med 353, 2477-2490, doi:10.1056/NEJMra043172 (2005).
3 Dutcher, J. P. Recent developments in the treatment of renal cell carcinoma. Ther Adv Urol 5, 338-353, doi:10.1177/1756287213505672 (2013).
4 Lam, J. S., Leppert, J. T., Figlin, R. A. & Belldegrun, A. S. Role of molecular markers in the diagnosis and therapy of renal cell carcinoma. Urology 66, 1-9, doi:10.1016/j.urology.2005.06.112 (2005).
5 He, L. & Hannon, G. J. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5, 522-531, doi:10.1038/nrg1379 (2004).
6 Nana-Sinkam, S. P. & Croce, C. M. MicroRNA regulation of tumorigenesis, cancer progression and interpatient heterogeneity: towards clinical use. Genome Biol 15, 445, doi:10.1186/s13059-014-0445-8 (2014).
7 Al-Ali, B. M., Ress, A. L., Gerger, A. & Pichler, M. MicroRNAs in renal cell carcinoma: implications for pathogenesis, diagnosis, prognosis and therapy. Anticancer Res 32, 3727-3732 (2012).
8 Wu, Q., Meng, W. Y., Jie, Y. & Zhao, H. LncRNA MALAT1 induces colon cancer development by regulating miR-129-5p/HMGB1 axis. J Cell Physiol 233, 6750-6757, doi:10.1002/jcp.26383 (2018).
9 Li, Z. et al. MiR-129-5p inhibits liver cancer growth by targeting calcium calmodulin-dependent protein kinase IV (CAMK4). Cell Death Dis 10, 789, doi:10.1038/s41419-019-1923-4 (2019).
10 Qiu, Z., Wang, X., Shi, Y. & Da, M. miR-129-5p suppresses proliferation, migration, and induces apoptosis in pancreatic cancer cells by targeting PBX3. Acta Biochim Biophys Sin (Shanghai) 51, 997-1007, doi:10.1093/abbs/gmz096 (2019).
11 Wang, Q. & Yu, J. MiR-129-5p suppresses gastric cancer cell invasion and proliferation by inhibiting COL1A1. Biochem Cell Biol 96, 19-25, doi:10.1139/bcb-2016-0254 (2018).
12 Wu, Z., Chen, D., Wang, K., Cao, C. & Xu, X. Long Non-coding RNA SNHG12 Functions as a Competing Endogenous RNA to Regulate MDM4 Expression by Sponging miR-129-5p in Clear Cell Renal Cell Carcinoma. Front Oncol 9, 1260, doi:10.3389/fonc.2019.01260 (2019).
13 Remold-O'Donnell, E., Zimmerman, C., Kenney, D. & Rosen, F. S. Expression on blood cells of sialophorin, the surface glycoprotein that is defective in Wiskott-Aldrich syndrome. Blood 70, 104-109 (1987).
14 Fu, Q. et al. Intracellular patterns of sialophorin expression define a new molecular classification of breast cancer and represent new targets for therapy. Br J Cancer 110, 146-155, doi:10.1038/bjc.2013.526 (2014).
15 Ebru, T. et al. Analysis of various potential prognostic markers and survival data in clear cell renal cell carcinoma. Int Braz J Urol 43, 440-454, doi:10.1590/S1677-5538.IBJU.2015.0521 (2017).
16 Wang, X., Li, H., Cui, L., Feng, J. & Fan, Q. MicroRNA-182 suppresses clear cell renal cell carcinoma migration and invasion by targeting IGF1R. Neoplasma 63, 717-725, doi:10.4149/neo_2016_508 (2016).
17 Jiang, L., Liu, Y., Ma, C. & Li, B. MicroRNA-30a suppresses the proliferation, migration and invasion of human renal cell carcinoma cells by directly targeting ADAM9. Oncol Lett 16, 3038-3044, doi:10.3892/ol.2018.8999 (2018).
18 Maolakuerban, N. et al. MiR-200c-3p inhibits cell migration and invasion of clear cell renal cell carcinoma via regulating SLC6A1. Cancer Biol Ther 19, 282-291, doi:10.1080/15384047.2017.1394551 (2018).
19 Chen, J., Shu, Y., Yu, Q. & Shen, W. MicroRNA-645 promotes cell metastasis and proliferation of renal clear cell carcinoma by targeting GK5. Eur Rev Med Pharmacol Sci 21, 4557-4565 (2017).
20 Yang, F. et al. MicroRNA-543 promotes the proliferation and invasion of clear cell renal cell carcinoma cells by targeting Kruppel-like factor 6. Biomed Pharmacother 97, 616-623, doi:10.1016/j.biopha.2017.10.136 (2018).
21 Gao, G. et al. miR-129-5p inhibits prostate cancer proliferation via targeting ETV1. Onco Targets Ther 12, 3531-3544, doi:10.2147/OTT.S183435 (2019).
22 Cao, J., Wang, Q., Wu, G., Li, S. & Wang, Q. miR-129-5p inhibits gemcitabine resistance and promotes cell apoptosis of bladder cancer cells by targeting Wnt5a. Int Urol Nephrol 50, 1811-1819, doi:10.1007/s11255-018-1959-x (2018).
23 Tuccillo, F. M. et al. Aberrant glycosylation as biomarker for cancer: focus on CD43. Biomed Res Int 2014, 742831, doi:10.1155/2014/742831 (2014).